tiprankstipranks
Republic Healthcare Limited (HK:8357)
:8357
Hong Kong Market
Want to see HK:8357 full AI Analyst Report?

Republic Healthcare Limited (8357) AI Stock Analysis

0 Followers

Top Page

HK:8357

Republic Healthcare Limited

(8357)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
HK$0.12
▲(0.83% Upside)
Action:ReiteratedDate:04/22/26
The score is driven primarily by weak financial performance (worsening losses, negative cash flow, and higher debt) and a bearish technical setup (price below key moving averages with negative MACD). Valuation offers limited support because the company is loss-making and no dividend yield is available.
Positive Factors
Conservative pre-2025 leverage
A multi-year record of low leverage through 2021–2024 implies the company historically maintained financial flexibility and creditor confidence. That track record increases the likelihood management can access capital or negotiate covenants during a turnaround, cushioning multi-month shocks.
Negative Factors
Worsening profitability and revenue decline
Consecutive double-digit revenue declines and a shift to a gross loss indicate structural pressure on demand, pricing or cost absorption. Persistent margin erosion reduces reinvestment capacity and makes achieving scale economics harder, lengthening any required operational turnaround.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative pre-2025 leverage
A multi-year record of low leverage through 2021–2024 implies the company historically maintained financial flexibility and creditor confidence. That track record increases the likelihood management can access capital or negotiate covenants during a turnaround, cushioning multi-month shocks.
Read all positive factors

Republic Healthcare Limited (8357) vs. iShares MSCI Hong Kong ETF (EWH)

Republic Healthcare Limited Business Overview & Revenue Model

Company Description
Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexu...

Republic Healthcare Limited Financial Statement Overview

Summary
Overall fundamentals are weak: profitability deteriorated sharply in 2025 with gross loss and large operating/net losses alongside declining revenue. Cash flow turned negative again in 2025 (negative operating and free cash flow), and debt increased materially, raising financial risk despite a still-meaningful equity base.
Income Statement
22
Negative
Balance Sheet
54
Neutral
Cash Flow
28
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.51M7.84M9.23M10.28M9.44M13.97M
Gross Profit1.67M-23.92K6.48M2.70M5.97M9.13M
EBITDA-1.30M-1.76M-188.79K29.34K-387.88K962.89K
Net Income-1.25M-2.96M-178.16K-855.12K-1.48M-997.93K
Balance Sheet
Total Assets13.65M16.14M14.48M15.64M16.42M19.27M
Cash, Cash Equivalents and Short-Term Investments9.75M6.85M11.52M11.93M11.83M14.27M
Total Debt1.25M5.03M858.22K961.16K810.47K1.55M
Total Liabilities2.34M6.59M1.93M2.89M2.30M3.67M
Stockholders Equity11.31M9.55M12.55M12.75M14.12M15.59M
Cash Flow
Free Cash Flow-1.22M-3.12M51.27K806.24K-1.16M-1.13M
Operating Cash Flow-1.15M-1.90M125.07K899.91K-734.46K-510.07K
Investing Cash Flow1.24M-2.22M-93.94K831.49K-987.23K-1.56M
Financing Cash Flow-560.42K-813.99K-531.65K-587.62K-689.73K2.28M

Republic Healthcare Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.12
Price Trends
50DMA
0.16
Negative
100DMA
0.14
Negative
200DMA
0.15
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
42.95
Neutral
STOCH
57.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8357, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.16, and below the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.95 is Neutral, neither overbought nor oversold. The STOCH value of 57.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8357.

Republic Healthcare Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
HK$156.96M5.316.92%8.00%-17.36%-29.80%
58
Neutral
HK$55.94M362.73-19.93%-2.91%55.41%
55
Neutral
HK$22.88M-197.60138.68%-20.81%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
HK$76.13M-2.02-27.01%-5.97%-1594.12%
42
Neutral
HK$148.80M-20.58-1449.22%-30.45%-734.38%
41
Neutral
HK$16.65M-2.2926.12%14.64%-81.95%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8357
Republic Healthcare Limited
0.12
0.02
19.61%
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
0.05
69.23%
HK:2293
Bamboos Health Care Holdings Ltd
0.39
-0.13
-25.00%
HK:8161
MediNet Group Ltd.
0.55
0.22
66.67%
HK:8307
Medicskin Holdings Ltd.
0.14
-0.03
-16.07%
HK:8437
RMH Holdings Limited
0.25
0.08
47.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 22, 2026